Seattle Genetics | Spese Di Vendita E Di Amministrazione



Spese Di Vendita E Di Amministrazione Cambiamento Data
AbbVie USD 3.89B 325M 2025-12
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
Amgen USD 1.94B 237M 2025-12
Astellas Pharma JPY 221.78B 14.94B 2025-12
Bayer EUR 3.4B 140M 2025-09
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Celldex Therapeutics USD 6.63M 546K 2025-09
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Eisai JPY 111.72B 7.86B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Esperion Therapeutics USD 39.98M 4.21M 2024-09
Exelixis USD 123.02M 19.9M 2025-12
Genmab DKK 144M 18M 2025-06
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Glaxosmithkline GBP 2.91B 817.89M 2025-09
Incyte USD 390.41M 61.33M 2025-12
Insmed USD 212.48M 26.11M 2025-12
Karyopharm Therapeutics USD 27.19M 442K 2024-12
MacroGenics USD 9.9M 600K 2025-09
Merck USD 2.85B 215M 2025-12
Moderna USD 308M 40M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Novartis USD 3.31B 134M 2025-09
Pfizer USD 4.08B 894M 2025-12
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Sanofi EUR 2.75B 455M 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Takeda JPY 282.78B 29.23B 2025-12
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Xencor USD 87.78M 72.66M 2025-09


Seattle Genetics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.